Imet Capsule

Introduction

Imet Capsule 25 mg is a nonsteroidal anti-inflammatory drug (NSAID) commonly used to reduce inflammation, pain, and fever. It is used to treat various conditions, including arthritis, gout, and other inflammatory disorders.

Uses

Imet Capsule 25 mg is used for:

Treating acute and chronic inflammatory conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.
Managing gout attacks and other forms of arthritis.
Reducing pain and inflammation following surgery or injury.
As an adjunct treatment for patent ductus arteriosus (PDA) in premature infants to help close the ductus arteriosus.

Brand Name	Imet
Type	Capsule
Weight	25 mg
Generic	Indomethacin
Manufacturer	Pacific Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Imet Capsule 25 mg works by inhibiting the activity of cyclooxygenase enzymes (COX-1 and COX-2), which are involved in the production of prostaglandins. Prostaglandins are compounds that mediate inflammation, pain, and fever. By blocking these enzymes, indomethacin reduces the synthesis of prostaglandins, thereby decreasing inflammation, pain, and fever.

How Long Does It Take to Work?

The onset of action for indomethacin can vary. Typically, oral formulations may take several hours to start providing relief, with noticeable effects often occurring within 1 to 2 days of consistent use. For acute conditions, such as gout attacks, patients might experience relief within a few hours after administration.

Absorption

Imet Capsule 25 mg is well absorbed from the gastrointestinal tract when administered orally. Peak plasma concentrations are generally reached within 1 to 2 hours after ingestion. It is also available in other forms such as rectal suppositories and intravenous injections, which can alter the absorption rate.

Route of Elimination

Imet Capsule 25 mg is primarily eliminated through the kidneys. It undergoes extensive hepatic metabolism, and its metabolites are excreted in the urine. A small proportion is also excreted in the feces.

Dosage

The dosage of indomethacin varies based on the condition being treated:

For osteoarthritis and rheumatoid arthritis: The usual oral dosage is 25-50 mg two to three times daily, with a maximum daily dose of 200 mg.
For acute gout: Initial doses of 50 mg every 8 hours for up to 4 days may be used.
For patent ductus arteriosus in infants: Typically, 0.2 mg/kg intravenously every 12 to 24 hours for 3 doses, with adjustments based on clinical response.

Administration

Imet Capsule 25 mg can be administered orally in the form of tablets or capsules, rectally as suppositories, or intravenously in hospital settings. The method of administration depends on the specific condition being treated and the urgency of treatment.

Side Effects

Common side effects include:

Gastrointestinal issues such as nausea, vomiting, abdominal pain, and diarrhea.
Headache, dizziness, and drowsiness.
Skin rash or itching.

Serious side effects can include:

Gastrointestinal bleeding or ulceration.
Renal impairment and fluid retention.
Cardiovascular events such as hypertension or heart failure.

Toxicity

Toxicity may occur with high doses or prolonged use and can lead to severe gastrointestinal bleeding, renal failure, or central nervous system effects such as confusion or seizures. In case of overdose, supportive care and symptomatic treatment are required.

Precautions

Precautions include:

Monitoring renal function and gastrointestinal health during prolonged therapy.
Avoiding use in patients with a history of peptic ulcer disease or gastrointestinal bleeding.
Using with caution in patients with cardiovascular disease, hypertension, or renal impairment.

Interaction

Imet Capsule 25 mg may interact with other medications, including:

Anticoagulants (e.g., warfarin), increasing the risk of bleeding.
Other NSAIDs or corticosteroids, which can enhance gastrointestinal toxicity.
Diuretics and antihypertensives, potentially reducing their effectiveness.

Disease Interaction

Use indomethacin with caution in patients with:

Pre-existing gastrointestinal disorders or a history of peptic ulcers.
Renal or hepatic impairment.
Cardiovascular conditions, such as heart failure or hypertension.

Drug Interaction

Imet Capsule 25 mg can interact with several drugs, including:

Anticoagulants: Increased bleeding risk.
ACE inhibitors: Possible reduction in antihypertensive effects.
Other NSAIDs: Increased risk of gastrointestinal adverse effects.

Food Interactions

Food does not significantly affect the absorption of indomethacin. However, taking it with food can help reduce gastrointestinal irritation. Avoiding alcohol is advised as it can increase the risk of gastrointestinal bleeding.

Pregnancy Use

Imet Capsule 25 mg is generally not recommended during pregnancy, particularly in the third trimester, due to potential risks to the fetus such as premature closure of the ductus arteriosus and other adverse effects. Consult a healthcare provider for alternatives and proper guidance.

Lactation Use

Imet Capsule 25 mg is excreted in breast milk in small amounts. While it is generally considered safe during lactation, it is best to consult a healthcare provider before use to ensure safety for both the mother and infant.

Acute Overdose

In the case of acute overdose, symptoms may include severe gastrointestinal bleeding, renal failure, or central nervous system disturbances. Treatment involves symptomatic management, supportive care, and possibly activated charcoal if ingestion was recent.

Contraindication

Imet Capsule 25 mg is contraindicated in individuals with:

Severe gastrointestinal disorders such as peptic ulcer disease or gastrointestinal bleeding.
Severe renal or hepatic impairment.
Hypersensitivity to indomethacin or other NSAIDs.

Use Direction

Use indomethacin as directed by a healthcare provider. Adhere to prescribed dosages and administration routes to minimize side effects and maximize therapeutic benefits.

Storage Conditions

Store indomethacin at room temperature, away from moisture and light. Ensure that it is kept out of reach of children and follow specific storage instructions provided with the medication.

Volume of Distribution

The volume of distribution of indomethacin is approximately 0.2 to 0.4 L/kg. It is distributed throughout the body, including tissues and fluids.

Half Life

The half-life of indomethacin is approximately 4 to 9 hours in healthy adults. This may vary based on factors such as liver function and renal health.

Clearance

Imet Capsule 25 mg is primarily cleared by the liver, with its metabolites excreted in the urine. The clearance rate may be affected by hepatic or renal impairment, necessitating dose adjustments in such cases.

See in details version Imet Capsule 25 mg also Imet Capsule 25 mg in bangla